EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Collagen I promotes cancer cell survival via amino acid import and mTORC1/S6 activation

Mona Nazemi, Bian Yanes, Eric Vancauwenberghe, Ifeoluwa Oyelade, Heather Walker, Elena Rainero iD

PLOS Biology · 2026

DOI: 10.1371/journal.pbio.3003555 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Biology, 2026. Verfasst von Mona Nazemi und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Biosciences, University of Sheffield, Sheffield, United Kingdom. Hauptthemen laut MEDLINE: Mechanistic Target of Rapamycin Complex 1, Breast Neoplasms, Amino Acids, Pancreatic Neoplasms. Die Arbeit nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Cancer Research UK, Breast Cancer Now.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Invasive breast and pancreatic cancer cells thrive within a collagen I-rich, poorly perfused extracellular matrix (ECM) network, necessitating robust metabolic adaptation to endure nutrient deficiency, such as glucose starvation. Here we demonstrate that collagen I is critical for the survival and growth of breast and pancreatic cancer cells. Mechanistically, collagen I promotes α2 β1 integrin-dependent S6 phosphorylation by the mammalian target of rapamycin complex 1 (mTORC1) and drives the membrane localisation of the LAT1−4F2hc amino acid transporter. This process ensures a sustained intracellular essential amino acid supply, further fuelling mTORC1 signalling and limiting autophagy. This collagen I-driven pathway is essential for cancer cell survival, as inhibiting the activity of α2 β1 integrin or the LAT1-4F2hc transporter significantly reduces cell growth and invasion in both 2D and 3D models. Finally, the clinical relevance of these transporters is underscored by the significant upregulation of LAT1-4F2hc expression in basal-like breast and pancreatic cancer patients, correlating with poor prognosis and drug resistance. Collectively, our findings highlight that targeting the LAT1−4F2hc transporter might represent a highly promising therapeutic strategy to limit cancer cell growth and invasion in highly fibrotic and nutrient-deprived tumours.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mechanistic Target of Rapamycin Complex 1Breast NeoplasmsAmino AcidsPancreatic NeoplasmsRibosomal Protein S6HumansCell Line, TumorCell SurvivalFemaleSignal TransductionFusion Regulatory Protein 1, Heavy ChainPhosphorylationLarge Neutral Amino Acid-Transporter 1Cell ProliferationAnimalsCollagenExtracellular Matrix

Substanzen

Mechanistic Target of Rapamycin Complex 1Amino AcidsFusion Regulatory Protein 1, Heavy ChainRibosomal Protein S6Large Neutral Amino Acid-Transporter 1Collagen

Autor:innen und Institutionen

  • School of Biosciences, University of Sheffield, Sheffield, United Kingdom.

ORCID-Profile: Elena Rainero

Förderung

  • Wellcome Trust
  • Cancer Research UK
  • Breast Cancer Now
  • Yorkshire Cancer Research

Zitieren

APA

Nazemi, M., Yanes, B., Vancauwenberghe, E., Oyelade, I., Walker, H., & Rainero, E. (2026). Collagen I promotes cancer cell survival via amino acid import and mTORC1/S6 activation. PLOS Biology. https://doi.org/10.1371/journal.pbio.3003555

Vancouver

Nazemi M, Yanes B, Vancauwenberghe E, Oyelade I, Walker H, Rainero E. Collagen I promotes cancer cell survival via amino acid import and mTORC1/S6 activation. PLOS Biology. 2026. doi:10.1371/journal.pbio.3003555

BibTeX
@article{Nazemi2026,
  author = {Nazemi, Mona and Yanes, Bian and Vancauwenberghe, Eric and Oyelade, Ifeoluwa and Walker, Heather and Rainero, Elena},
  title = {Collagen I promotes cancer cell survival via amino acid import and mTORC1/S6 activation},
  journal = {PLOS Biology},
  year = {2026},
  doi = {10.1371/journal.pbio.3003555}
}
Kostenlos starten →